# Kompass Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kompass-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.kompassdx.com/
- Total disclosed funding: $1.6M
- Latest round: Seed (Nov 11, 2024)
- Investors on record: 3

## About

Based in Illinois, US, founded in 2022 by co-founders Mingoo Kim, Hyouarm Joung, and Hyunjune Jang, Kompass Diagnostics Inc. is a provider of fertility care and developed a solution that allows individuals to track fertility hormones. In November 2024, Kompass Diagnostics raised KRW 2.2 billion in seed funding from investors Bass Ventures, Kakao Ventures, and Digital Healthcare Partners.

The company’s flagship product, the Kompass system, provides a platform for remote fertility monitoring. The test supports the measurement of eight key fertility hormones using finger-prick blood samples. The system offers options for self-administration or assisted testing through a digital platform to ensure safe communication and data sharing.

## Funding rounds

- Seed, Nov 11, 2024, $1.6M — Kakao Ventures, Bass Ventures, Digital Healthcare Partners

## Investors

- Kakao Ventures (https://capitalatlas.ai/funds/kakao-ventures) — Seed
- Bass Ventures (https://capitalatlas.ai/funds/bass-ventures) — Seed
- Digital Healthcare Partners (https://capitalatlas.ai/funds/digital-healthcare-partners) — Seed